Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-16 @ 3:41 PM
Study NCT ID:
NCT03838159
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-09
First Post:
2019-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NADIM II: Neo-Adjuvant Immunotherapy
Sponsor:
Fundación GECP
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GECP 18/02_NADIM II
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None